UBS maintains Qiagen at Neutral, PT $50.00

UBS maintains Qiagen at Neutral, PT $50.00

An UBS analyst maintained Qiagen (NYSE: QGEN) at Neutral and a price target of $50.00 from a prior price target of %currency%%price%.

Prior to this rating, Qiagen had 6 buy ratings, 8 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Qiagen, click here. For more news on Qiagen, click here.

Qiagen's stock price closed at $45.98. They are up 0% in the last month and up 0.44% in the last 12 months.

According to Investing Pro, Qiagen's fair value is $47.41, an upside of 3.12%. Qiagen's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Qiagen's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles